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ABSTRACT 
 
Endothelial and Smooth Muscle-Dependent Vascular Reactivity In Immature 
Arterialized Collateral Capillaries  
 
Caitlin Koeroghlian 
 
 Peripheral arterial occlusive disease (PAOD) occurs due to the build up of atherosclerotic 
plaque and reduces blood flow to cause chronic ischemia. Patients with PAOD may experience 
intermittent claudication, or the pain in limb skeletal muscles due to a decease in blood flow. 
Collateral arteries can act as a natural bypass and improve blood flow to hypoxic tissue by 
creating an alternate route for blood to flow, but not all patients with PAOD have pre-existing 
collateral networks. Animal studies indicate that tissues without pre-existing collateral networks 
can form de novo collaterals from capillaries following occlusion of a feed artery. Unfortunately, 
theses de novo collaterals, termed arterialized collateral capillaries (ACCs) lack functional 
vasodilation at day-7 following feed artery occlusion. To induce the formation of ACCs, we 
ligated the lateral feed artery in the spinotrapzeius muscle in Balb/c mice. We evaluated the 
potential mechanism of impaired functional vasodilation in immature arterialized collateral 
capillaries (7 days following occlusion) by measuring endothelial-dependent vasodilation to 
bradykinin and endothelial-independent vasodilation to isoproterenol and sodium nitroprusside. 
Vasodilation to both the endothelial-dependent and endothelial-independent vasodilators was 
impaired in the immature ACCs as compared to the terminal arterioles on the unoperated sham 
side. Similar responses to the endothelial cell and smooth muscle cell-dependent vasodilations 
suggest that impaired functional vasodialtion is due to impaired vascular smooth muscle cell 
function, which is consistent with our preivous research. We speculate that the SMCs of the 
ACCs are immature and  may still be remodeling, rearranging, or modulating phenotype in the 
newly formed collaterals. Determining factors to induce mature arterialized collateral capillaries 
in patients with PAOD lacking pre-existing collateral netoworks could reduce ischemia and 
improve prognosis.  
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“I believe there are no questions that science can’t answer about a physical universe.” 
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 INTRODUCTION 
Clinical Relevance 
 
 Peripheral arterial occlusive disease (PAOD) is a serious 
chance of coronary heart disease. It 
stenosis of arteries and reduced blood fl
buildup of plaque in arteries and can lead to chronic ischemia, the decrease in blood flow to 
tissue, and impede function in microcirculation (
leads to cramping and pain in skeletal limb muscles due to the insufficient delivery of oxygen 
and nutrients. Intermittent claudication, or hypoxic pain during locomotion, is the most common 
symptom of PAOD and is intensi
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 Treatments for PAOD seek to manage symptoms of the disease, reduce atherosclerotic 
plaque, and restore blood flow to ischemic regions. Common treatments include lifestyle 
modifications and pharmaceuticals that aim to reduce the intermittent claudication. More 
serious cases of PAOD may require stenting or bypass surgery. Bypass surgery involves using 
an autologous saphenous vein to bypass the occluded artery and restore blood flow. Yet not all 
patients are eligible for bypass surgery due to pre-existing conditions or the lack of a robust vein 
to serve as a conduit. Therefore, developing alternate treatments for PAOD is necessary to 
benefit all patients. Natural bypass vessels can improve prognosis of patients with PAOD by 
providing blood flow around the occluded artery. Collateral vessels provide blood flow to 
ischemic areas by bypassing the diseased vessel, and the growth of collateral arteries can be a 
life-saving occurrence after an arterial occlusion [18]. 
Previous Work 
 
Pre-existing collateral networks improve the prognosis of patients with PAOD, but not 
all patients have robust collaterals and need an alternative for redirecting blood flow [14]. 
Animal studies indicate that genetic background strongly influences the number and remodeling 
of pre-existing collateral arteries, suggesting that patients who lack robust collaterals may either 
lack pre-existing collaterals or exhibit impaired arteriogenesis. The mechanisms of 
arteriogenesis are being studied in different models in order to enhance the process of collateral 
formation in patients with PAOD [7]. Studies on the microcirculation in different mice strains 
show that it is possible to evaluate two types microcirculation networks in Balb/c and C57 mice.  
Balb/c mice have a dendritic, unconnected arteriole tree structure whereas C57s have an 
arcade structure with many arteriole-to-arteriole connections. Accordingly, with fewer, if any, 
pre-existing collaterals, collateral vessels in Balb/c mice form by remodeling at the capillary 
 3 
level after an occlusion [14]. Collateral vessels provide increased blood flow to ischemic areas 
of tissue, therefore it is important to understand the formation of arterialized collateral 
capillaries in ischemic models lacking pre-existing collaterals.  
Arterialized collateral capillaries (ACCs) can form in animals that lack pre-existing 
collaterals when an occlusion is present, and allow blood to flow around the occlusion through a 
robust capillary [14]. In order for sufficient blood to flow to the ischemic region, the ACCs 
must exhibit functional vasodilation, which is impaired at certain time points in animal models 
and can prevent sufficient blood flow during strenuous activities [9]. 
Balb/c mice showed no functional vasodilation in arterialized capillaries 7 days post 
ligation, suggesting the ACCs were immature at this time point [3]. Achytalcholine (EC-
dependent), sodium nitroprusside (SMC-dependent), and norepinephrine (SMC-dependent) 
reagents were applied to the spinotrapezius muscle of Balb/c mice, the results from which 
suggested that the impairment of vasodilation at 7 days post ligation is due to smooth muscle 
cell impairment [9]. It is important to study the impairment of collateral vessels in different 
models to understand how recovery from an occlusion can be accelerated.  
Endothelial-Dependent Dilation 
 
 Bradykinin (BK), isoproterenol (ISO), and sodium nitroprusside (SNP) were applied to 
the spinotrapezius muscle of Balb/c mice in a physiological salt solution seven days post 
ligation to understand the vascular reactivity in arterialized collateral capillaries. Endothelial 
dependent (bradykinin) and endothelial independent (isoproterenol and sodium nitroprusside) 
reagents were utilized to test the different pathways that cause smooth muscle cells to relax and 
provide functional vasodilation of arterioles. Endothelial cells cause smooth muscle cells to 
relax through different pathways [16]. 
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Bradykinin is an endothelial-dependent agonist that interacts with G protein coupled 
receptors (GPCR) at the endothelial cell surface [6]. The binding of BK to the GPCR activates 
phospholipase C (PLC) and causes an increase in cytoplasmic calcium and diacylglycerol 
(DAG) levels [10,17]. The surplus of intracellular calcium binds to calmodulin (Cam) and 
phosphorylates eNOS to promote the synthesis of NO [19]. NO is released into smooth muscle 
cells where it binds to soluble guanylyl cyclase receptors (sGC) [7, 4]. The activation of sGC 
increases cGMP production, activating protein kinase G (PKG) that phosphorylates myosin 
light chain kinase. Phosphorylation inhibits MLCK and decreases the interaction between actin 
and myosin, causing relaxation and vasodilation [2]. BK can increase blood flow and improve 
myocardial metabolism through vasodilation of microvessels [11].  
 
Figure 2: Endothelial-dependent vasodilation. Bradykinin acts through the GPCR on 
endothelial cells in microvasculature to cause dilation of smooth muscle cells [15]. 
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Previous research examined the impairment of vasodilation in vasculature using 
acetylcholine (Ach), another endothelial-dependent agonist that acts through a different signal 
transduction pathway.  Ach targets the GPCR and activates the protein kinase A (PKA) in the 
GPCR cascade [14, 8]. There was no endothelial impairment of vasodilation in immature 
arterialized capillaries when stimulated with Ach [9], beyond the smooth muscle cell 
impairment that was observed.  
Smooth muscle cells in microvasculature are able to relax independently of endothelial-
derived factors. Smooth muscle cell-dependent dilators, such as epinephrine, acts through beta-
adrenergic receptors to relax the smooth muscle cells in microvasculature. Beta-adrenergic 
receptors are GPCRs, that when stimulated by their agonist, cause the dissociation of the Gα 
subunit and the activation of adenylyl cyclase. Adenylyl cyclase (AC) catalyzes the conversion 
of ATP into cyclic-AMP (cAMP) and the cAMP phospohorylates cAMP-dependent PKA, 
which phosphorylates MLCK. Phosphorylation of the MLCK causes a decrease in activity, 
hyperpolarization and relaxation of the smooth muscle cells [12]. Isoproterenol is a nonselective 
beta-adrenergic agonist that stimulates beta-receptors and causes relaxation of arterioles by 
directly targeting smooth muscle cells. 
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Figure 3: Beta-adrenergic signaling cascade. Endothelial-independent dilators cause smooth 
muscle cell relaxation through the dissociation of the Gα subunit [21]. 
 
 Sodium nitroprusside is a smooth muscle cell-dependent vasodilator that bypasses the 
endothelial activation of the GPCR.  SNP is converted into NO that diffuses directly into the 
SMCs and causes vasodilation through an increase in cGMP and the phosphorylation of the 
myosin light chain kinase. Sodium nitroprusside acted as a control in this study, as previous 
studies have analyzed the effect of SNP on vasodilation of immature arterialized capillaries in 
Balb/c mice and saw impaired vascular reactivity through the NO pathway [9].  
 These reagents were chosen to target specific cell types and extend the work of previous 
studies that utilized Ach, SNP and NE to examine impaired vascular reactivity in arterialized 
capillaries. 
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Specific Aims 
 It is hypothesized that the impaired vasodilation in immature arterialized collateral 
capillaries is due to smooth muscle cell impairment. If the SMC is impaired, we expect to see 
similar responses in the ACCs to BK and ISO on the ligated side as well as similar responses 
between BK and Ach and ISO and SNP [9]. Arterialized collateral capillary formation can 
benefit patients that lack pre-existing collateral networks and to maximize the benefit of 
collaterals, the ACCs must be capable of regulating blood flow and exhibiting functional 
vasodilation.  
Specific Aim 1: To assess the reactivity of terminal arterioles in unoperated mice and 
identify the lowest concentration of BK and ISO necessary to achieve maximum vasodilation. 
Specific Aim 2: To test the hypothesis that smooth muscle cell-dependent vasodilation is 
impaired in arterialized collateral capillaries 7 days post ligation of the lateral feed artery in the 
spinotrapezius muscle. 
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METHODS 
Animal Care 
 Male Balb/c mice were used in the procedures in accordance with protocols approved by 
the Institutional Animal Care and Use Committee (IACUC) of California Polytechnic State 
University, San Luis Obispo. Mice were housed in the University Vivarium and were monitored 
daily for food and water levels. 
Lateral Feed Artery Ligation  
 Ligations were performed to occlude the lateral feed artery and induce the formation of 
ACCs in the spinotrapzeius muscle. Buprenorphine analgesic (0.075 mg kg-1) was 
subcutaneously administered after the mouse was anesthetized with 5% isoflurane in oxygen 
flowing at 3-5 l⋅min-1. The mouse was then transferred to the heat pad on the surgical stage 
where a nose cone administered ~1-3% isoflurane flowing at 0.5-1.0 l⋅min-1. The heat pad was 
set to 35° C for the duration of the procedure and the temperature was monitored with a rectal 
probe. The hair on the dorsal region of the mouse was removed prior to the surgery with 
clippers and depilatory cream, and veterinary ointment was applied to the corneas to prevent 
corneal desiccation.  
 Using aseptic technique, a small incision was made above the cranial, lateral edge of the 
spinotrapezius muscle, where the fat pad overlays the muscle. The fat pad, cranial and 
superficial to the spinotrapezius, was blunt dissected to expose the lateral edge; the site was 
frequently irrigated with phosphate buffered saline (PBS) to prevent desiccation. The lateral 
feed artery was isolated and ligated with single strands from 6-0 silk suture (Figure 2). The 
initial incision was closed with 7-0 polypropylene suture. Sham-side surgeries were performed 
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to induce similar trauma to the area without ligating the artery. Immediately following surgery, 
buprenorphine analgesic was administered subcutaneously (0.075 mg·kg-1). The operated mouse 
was returned to the vivarium and given oral buprenorphine (0.01 mg⋅mL-1) for two days 
following surgery. 
 
 
Figure 4: Spinotrapezius artery feed ligation. A. Schematic of spinotrapezius muscle.  
B. Balb/c vasculature lacking collaterals [14]. 
 
Vascular Reactivity 
 Seven days post ligation, the spinotrapezius muscle was exposed to vasoactive agents on 
both the ligated and sham side to examine endothelial-dependent and endothelial-independent 
vasodilation of arterialized collateral capillaries (ACCs). 
 The mouse was prepared as described above, except the procedure was not performed 
aseptically and no analgesic was administered. Figure 5 displays the experimental configuration 
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and a schematic including the flow parameters. 
 An initial incision was made at the right caudal region of the spinotrapezius muscle and 
the incision was extended along the distal portion of the muscle to reveal the muscle. The 
connective tissue above the spinotrapezius muscle was removed using micro-dissection scissors 
and fine forceps. During the procedure, the muscle was continually irrigated with physiological 
salt solution (PSS) at a flow rate of ~2 mL min-1. The PSS was deoxygenated with 5% CO2 – 
95% N2 and warmed to 35° C.   
 After the connective tissue was removed, the intravital microscope (Microscan 
MIcrovision Medical) was placed over the muscle to visualize the microvasculature of the 
muscle, and the surgical stage was adjusted to locate the area of interest on the muscle. A 30-
minute equilibration period was undergone between dissection and the addition of the first 
dilator as well as in between the addition of each dilator to allow the vessels to return to rest. In 
the pilot study, different concentrations, from 10-8 to 10-4, were added with a micropipette to the 
PSS for both Bradykinin and Isoproterenol, with a five minute wait period between each 
concentration—recordings were taken at each time point—and the reactivity of the terminal 
arterioles was determined. In the second study, the optimal amount, 10-5 M, of each vasoactive 
agent (bradykinin, isoproterenol, and sodium nitroprusside) was added to the PSS to study the 
reactivity of the arterialized collateral capillaries. Ten-second videos were recorded before, and 
five minutes after the addition of each reagent. The same procedure was followed for the sham 
side, following the lateral feed artery to examine terminal arterials of similar size. Upon 
completion, the mouse was euthanized by cervical dislocation. 
 Figure 5: Intravital microscopy superfusion s
with microscan and heated syringe. B. Close up of mouse with heat pad and Microscan. 
 
Imaging and Statistical Analysis
 Automated Vascular Analysis (
conduct measurements of the arteriole diameter. Measurements were performed on the 
stabilized images to determine the difference in arteriole diameter before and after exposure to 
the reagents.  Statistical analysis was performed on the data generated from the images in the 
AVA software to compare the diameters for the varying concentrations of reagent
points as well as to compare the diameter changes on the operated and sham sides
ANOVA tests were performed on the data, with post
location of significant differences.
et-up. A. Representative image of preparation 
C. Schematic of flow. 
 
AVA) software was used to stabilize the videos and 
-hoc Tukey’s tests used to determine the 
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RESULTS 
 The first objective of the project was to complete a pilot study that involved measuring the 
vasodilation of small terminal arterioles in response to increasing doses of isoproterenol (SMC 
dep) and bradykinin (EC dep), 10-7 to 10-4 M, and sodium nitroprusside (SMC dep) to identify 
the lowest concentration necessary to achieve a maximum dilation, Figure 6. Swiss-Webster 
mice from the Cal Poly colony were used to conduct the pilot study due to similarity to Balb/c 
mice and easy availability.  
 
 
Figure 6: Superfusion dosage response in unoperated mice. Line graph displays change in 
diameter (µm) before and after log-increasing doses of bradykinin (BK) and isoproterenol (ISO) 
(n=5). 
  
Based on the results from the pilot study, we determined that the optimal concentration 
for both bradykinin and isoproterenol was 10-5M, which represented the plateau of the dose 
response “S” curve, in which diameter did not significantly increase with the next log dilution 
(determined after running repeated measures ANOVA for each reagent). Sodium nitroprusside 
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was previously determined to have optimal vascular reactivity at 10-5 M [9].  After completing 
the pilot study, the main objective of this project was to test the hypothesis that smooth muscle-
dependent vasodilation is impaired in immature arterialized capillaries. At day 7 following 
lateral feed artery ligation, we measured vasodilation of arterialized collateral capillaries in 
response to 10-5 M BK, ISO and SNP, Figure 7.  
On the sham side, the vasoactive agents induced significant vasodilation from rest (7 ± 
0.5 µm) when exposed to BK (12 ± 0.5 µm), ISO (13 ± 0.5 µm) and SNP (12 ± 0.5 µm). The 
arterialized collateral capillaries on the ligated side also experienced vasodilation from rest (7 ± 
0.5 µm) when exposed to BK, ISO, and SNP. Although the ACCs vasodilated in response to the 
vasoactive agents, for ISO there was less dilation on the ligated side (10 ± 1 µm) compared to 
dilated diameter on the sham side (13 ± 0.5 µm). For SNP, there was also a significant decrease 
in dilated diameter on the ligated side (10 ± 0.5 µm) compared to the sham side (12 ± 1 µm), 
Figure 7.  
 Figure 7: Vascular reactivity of arterialized collateral capillaries. 
of an arterialized collateral capillary pre and post exposure to BK. B. Diameters (um) pre 
post exposure to 10-5 M BK (n=7). C. Diameters 
(n=7). D. Diameters (µm) pre and post exposure to 10
baseline. + p<0.05 difference between sham and ligated
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  The percent change of each vessel diameter was compared
to determine if there was impaired vasodilation in the immature arterialized collateral 
capillaries, Figure 8. 
    
Figure 8: Relative reactivity of 
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When exposed to bradykinin, the terminal arterioles on the sham side had a larg
percent change in diameter (80 ±
ligated side (44 ± 7). In response to the isoproterenol, the terminal arterioles on the sham side 
had a larger percent change in diameter (
7). Sodium nitroprusside also elicited a larger percent change in diameter of the terminal 
arterioles (99 ± 7) compared to the ACCs (36
 
0
20
40
60
80
100
120
%
 C
h
a
n
g
e
 i
n
 D
ia
m
e
te
r
 on the sham and ligated side
 
arterialized collateral capillaries. Percent change in diameter 
 for sham versus 
ligated. 
 5) compared to the arterialized collateral capillaries on the 
79 ± 6) compared to the ACCs on the ligated side (44
 ±8).  
BK ISO SNP
sham
ligated
* *
*
15 
 
er 
 ± 
 16 
DISCUSSION 
Clinical Significance 
 Peripheral arterial occlusive disease can lead to chronic ischemia and intermittent 
claudication due to a plaque buildup in limb arteries. Collateral vessels can act as natural 
bypasses to provide improved blood to this ischemic region flow for patients with POAD, but 
pre-existing collateral networks are not always present in patients with ischemia. In animal 
models of chronic ischemia, arterialization of collateral capillaries, by arteriogenesis, can 
restore blood flow to the ischemic region. However, to provide sufficient blood flow, the 
collateral vessels must exhibit functional vasodilation, the vessels must be able to dilate in 
response to increased tissue metabolism. Arterialized collateral capillaries in Balb/c mice have 
impaired vasodilation 7 days post artery ligation, but dilate normally at day 21 [9]. The goal of 
this study was to confirm the impaired smooth muscle cell-dependent responses in the 
arterialized collateral capillaries.  
Vascular Reactivity 
Endothelial cell-dependent vasodilation was tested using bradykinin, an endothelial-
dependent agonist. The immature arterialized collateral capillaries exposed to bradykinin 
showed significant, but impaired vasodilation compared to the terminal arterioles on the sham 
side. Bradykinin targets the GPCRs on the endothelial cells lining the arteriole wall and through 
the GPCR cascade, causes the formation of nitric oxide, which is released into the smooth 
muscle cells and causes relaxation. It is unknown which part of the pathway is inhibited and 
further testing of the endothelial-dependent pathway should be tested. Specifically the GPCR 
cascade in the endothelial cell, separate from the smooth muscle cell response, should be tested 
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to confirm impairment of the endothelial-dependent vasodilation. The results do not confirm or 
refute impaired vascular reactivity due to endothelial cell impairment. 
 Smooth muscle cell-dependent agonists, isoptorterenol and sodium nitroprusside, which 
cause vasodilation in microvasculature, were applied onto immature arterialized collateral 
capillaries at day 7 following an artery occlusion. The decrease in vascular reactivity in the 
ACCs compared to the terminal arterials indicates that smooth muscle cells are impaired in 
immature arterialized collateral capillaries 7-days post ligation. SNP and ISO cause vasodilation 
through different pathways in the smooth muscle cells; SNP breaks down into NO which 
increases cGMP and leads to the phosphorylation of MLCK, whereas ISO targets the beta-
adrenergic receptor to activate adenylyl cyclase, increase cAMP and ultimately phosphorylate 
the MLCK to prevent contraction and induce vasodilation. The results indicate that both types 
of pathways that lead to vasodilation in the immature arterialized collateral capillaries are 
impaired. SNP had a larger trending change in percent difference from sham to ligated, but 
showed no significant difference compared to ISO, which could indicate that the pathways have 
various levels of impairment. 
 By testing the vascular reactivity of the arterialized collateral capillaries in response to 
bradykinin, isoproterenol, and sodium nitroprusside, we were able to determine that the smooth 
muscle cells at day 7 following an artery ligation contribute to impaired vasodilation, but it is 
unknown what causes impairment of vascular smooth muscle cells. 
Smooth Muscle Cell Phenotype 
 Vascular smooth muscle cells (VSMC) are categorized based on contractile properties, 
with considerable phenotypic diversity in various vessels throughout the body [5]. VSMC 
phenotype is related to varying developmental origins and can be influenced by the outward 
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remodeling of the vessel due to arteriogenesis [18, 16]. Structural remodeling could contribute 
to different smooth muscle contractile phenotypes and reduced vasodilation capacity.  
Arterialization of the capillaries occurs when capillaries recruit smooth muscle cells and 
gain the ability to dilate and contract, but the contractile ability is not fully functional at the 
onset of arteriogenesis. Changes in the myosin light chain and myosin heavy chain during the 
remodeling phase could enhance the vessels response to external stimuli with respect to the 
regulation of blood flow [5]. Different vessels express various phenotypes that allow for 
different levels of vasomotion and vascular smooth muscle phenotype may be driven by 
innervation, load, or other varying external signal [5]. 
Future Work 
To understand why smooth muscle cells are impaired in ACCS at day 7 following an 
artery ligation, future research should study the remodeling of the vascular smooth muscle cells 
and the changes in the myosin light chain and myosin heavy chain isoforms during 
arteriogenesis. Impairment of the vasodilation could be due to the change in phenotype and 
migration of SMCs to the capillaries during arterialization and remodeling [18].  
Examining vascular remodeling at the cellular level would help explain the lack of 
functional vasodilation by understanding how the cells are arranged and changing between day 
7 and day 21 after arterialization of the collateral capillary.  
Limitations 
 One limitation in this experiment was the accuracy of the dosage response curves 
created in the first part of the study. There was a large standard error associated with the 
vascular reactivity of both the BK and ISO reagents on terminal arterioles in the unoperated 
mice. It is possible that in the arterialized collateral capillaries there was normal vasodilation at 
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lower doses and only impaired vasodilation at higher doses, thus changing the interpretation of 
the data in the first part of the study. An inaccuracy in selecting the optimized dosage could 
have resulted in a discrepancy in the percent change of the ACC diameter.  
Summary 
 Functional vasodilation in immature arterialized collateral capillaries is impaired, to 
some extent, due to smooth muscle cell impairment at day 7 following occlusion of the lateral 
feed artery. The impairment of smooth muscle cells in the newly formed collateral vessels can 
hinder the recovery of ischemia and fail to match blood flow with tissue metabolic demand. If 
the smooth muscle cell recruitment and regeneration is better understood, it may be possible to 
induce the formation of mature, functional arterialized collateral capillaries after an occlusion. 
Therefore, understanding the cause of impairment is important to more effectively increase 
blood flow to the ischemic region, reduce the duration of impaired vasodilation, and may 
provide the foundation for future treatments for patients with PAOD.  
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APPENDIX 
Vascular Reactivity checklist and protocol 
 
Date ______________ Intravital Microscopy with Superfusion Initials ___________ 
 
Mouse Information 
DOB: ______________________   
Sex: _______________________    
Tag: _______________________   
Genotype/strain: _____________ 
Cage: ______________________   
Weight: ____________________ 
 
Materials 
____1.
 forceps (1) 
____2. fine forceps (1) 
____3. ultrafine forceps (2) 
____4. fine scissors (1) 
____5. ultrafine scissors (1) 
____6. 60mL syringe 
____7. bubbler (2) 
____8. volumetric flask 
____9. Kim wipes 
____10. Vasodilator/vasoconstrictor 
____11. 20X PSS 
____12. 20X NaHCO3 
____13. non-sterile cotton swabs 
____14. non-sterile cotton gauze 
____15. 10mL Graduated cylinder 
____16. stopwatch 
 
Instrument Preparation 
____17. Turn on ultrasonic bath to 45ºC 
____18. Transfer 50mL of 20x PSS into 1L volumetric 
flask 
____19. Transfer 50mL of 20x NaHCO3 into 1L volumetric 
flask 
____20. Dilute PSS & NaHCO3 to 1L with 18MΩ H20 
____21. Place 1L volumetric flask in water bath, using 
weight if necessary 
____22. Fill syringe in syringe heater with 50mL of 1x PSS 
& turn on syringe heater 
____23. Place thermister in syringe heater 
____24. Weigh out or thaw vasodilator 
 
Surgery preparation 
____25. Weigh animal in weight boat 
____26. Place animal in anesthesia box 
____27. Open the oxygen cylinder and set anesthesia-
machine flow meter to ~3 l·min-1 
____28. Anesthetize animal w/ 5% isoflurane 
____29. Reduce flow rate to 0.5-1.0 l·min-1 and the 
isoflurane to 1-3% 
____30. Lay animal supine on preparation bench with nose 
in nose-cone 
____31. Use trimming clippers & depilatory cream to 
remove hair superficial to spinotrapezius 
____32. Transfer mouse to stage on FST heat pad 
____33. Insert rectal probe and set thermo-controller to 
35°C 
____34. Open stopcock on delivery tubing to check flow 
rate of superfusion solution and use thermister to 
measure temperature 
____35. Adjust flow rate or temperature to achieve 
~2mL·min-1 and ~35ºC at tip 
 
Measurement preparation 
____36. Make an incision (1cm) at the caudal end of the 
spinotrapezius 
____37. Extend the incision cranially to the fat pad, 
creating a horse shoe incision 
____38. Blunt dissect the subcutaneous connective tissue to 
maximize surgical exposure 
____39. Maximize visibility of muscular branch- minimize 
contact/trauma of the artery 
 
Intravital Microscopy 
____40. Recheck flow rate and temperature of supefusion 
solution 
____41. Place microscan in stand and insure proper 
connectivity to computer. 
____42. Open AVA and create new folder containing date 
of procedure and make current folder. 
____43. Select capture on AVA main menu for microscan 
imaging 
____44. Label patient I.D. with the number of patient first 
followed by left or right hind limb or sham for 
control hind limb. 
EX: 25LeftACh8 
____45. Locate muscular branch and adjust microscan for 
best resolution. 
____46. Position superfusion delivery tubing with ball-
bearing manipulator at microscan lens to ensure 
flow over the artery 
____47. Place kim-wipe wick on side of animal (avoid 
contact with muscle) 
____48. Use AVA to measure muscular branch diameter 
after 30 minutes of stabilization. 
____49. Ensure that 60mL syringe contains 60mL of PSS 
____50. Add dose of first vasodilator agent 
____51. Allow superfusion to flow for 5 minutes and 
record video in the final minute 
____52. Empty 60mL syringe, rinse with 18MΩ H2O 
____53. Refill syringe with 60mL of PSS and repeat 
superfusion with 2nd and 3rd vasoactive agents 
____54. Repeat procedure on the contralateral limb 
 
Analysis 
____55. Open analysis section in AVA and open file of 
interest 
____56. Set Frames from 0 to 160 and stabilize file 
____57. Analyze vessel diameter by manually drawing 
diameter and chaining sections together 
____58. Record results in provided table 
 
Post-Experiment 
____59. Cervical dislocation to euthanize animal 
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Date ______________ Intravital Microscopy with Superfusion Initials ___________ 
____60. Rinse superfusion line (bubbler, superfusion tubing, 
syringe, & side-arm flask) with water (flush tubing 
w/ syringe) 
____61. Flush superfusion line with 1M HCl & rinse with 
water 
____62. Flush superfusion line with 18MΩ H2O  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Limb 1 
Left  or  Right 
BK Resting Diameter______________________________ 
BK volume & concentration________________________ _ 
BK dose 1 Diameter _______________________________   
ISO Resting Diameter______________________________ 
ISO volume & concentration  _______________________   
ISO Diameter ________________________________ ____  
SNP Resting Diameter_____________________________ 
SNP volume & concentration  _______________________   
SNP Diameter ________________________________ ___  
 
 
Limb 2 
Left  or  Right 
BK Resting Diameter______________________________ 
BK volume & concentration________________________ _ 
BK dose 1 Diameter _______________________________   
ISO Resting Diameter______________________________ 
ISO volume & concentration  _______________________   
ISO Diameter ________________________________ ____  
SNP Resting Diameter_____________________________ 
SNP volume & concentration  _______________________   
SNP Diameter ________________________________ ___  
 
 
Notes 
 ________________________________ _______________  
 ________________________________ _______________  
 ________________________________ _______________  
 ________________________________ _______________  
 ________________________________ _______________  
 ________________________________ _______________  
 ________________________________ _______________  
 
